From IVF Science to Skincare: A New Frontier in Fertility Patient Care

LONDON, UK – May 21, 2026 – A company founded by the same minds that revolutionized in-vitro fertilization (IVF) is now turning its attention from the petri dish to the skin. AV Laboratories, a skincare firm with deep roots in reproductive medicine, is set to launch a new program at a major European fertility conference, aiming to integrate science-backed skincare into the patient care model of fertility clinics.

The initiative, which will be unveiled at the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE 2026) in London this July, represents a significant move to bridge the gap between clinical treatment and holistic wellbeing. By targeting fertility specialists directly, AV Laboratories is betting that skincare should be seen not as a cosmetic luxury, but as an essential component of supporting women through the physically and emotionally demanding journey of fertility treatment, pregnancy, and early motherhood.

The Minds Behind the Molecules

The credibility of this venture is anchored in the formidable track record of its founders, Ami and Monica Mezezi. Before entering the world of skincare, the Mezezis were instrumental figures in the IVF industry through their company, LifeGlobal. They are widely credited with pioneering and commercializing single-step culture media, a breakthrough that simplified the process of growing embryos in the lab and contributed to a new standard of care in fertility clinics worldwide. The success and impact of LifeGlobal were solidified when it was acquired by the women's health giant CooperSurgical in 2016 for a reported $195 million.

This background in cellular science and precision-driven medical technology is the cornerstone of AV Laboratories' philosophy. The company is framing its return to the ESHRE conference—a gathering of the scientific community that shaped its founders' careers—as a homecoming with a new mission.

“ESHRE is deeply personal for us because this is the community that shaped our scientific foundation,” said Ami Mezezi, CEO and Co-Founder of AV Laboratories, in a statement. “Our work in IVF taught us how profoundly cellular health, precision, and care matter. With AV Laboratories, we are bringing that same philosophy into skincare, helping women feel supported through some of the most important and sensitive stages of their lives.”

This transition from developing media for embryos to creating serums for skin is less of a leap than it might appear. Both disciplines are fundamentally concerned with cellular nourishment, environmental stability, and creating optimal conditions for health and growth.

Science-Led Skincare for a Conscious Consumer

At the heart of the company's product line is AVL SOM3®, a patented molecular technology. According to AV Laboratories, this complex is inspired by its founders' work in cellular nourishment and is designed to support key building blocks associated with skin health and longevity, including collagen, elastin, and NAD+, a coenzyme critical for cellular energy and repair that has become a focal point of anti-aging research.

While the proprietary nature of AVL SOM3® means independent, peer-reviewed studies are not yet publicly available—a common scenario for new commercial technologies—the company emphasizes its commitment to clinical validation and formulation excellence.

"At AV Laboratories, we don’t formulate in isolation,” explained Sylwia Pawlaczyk, the company's COO and Master Formulator. “I spend a lot of time thinking about how we build the company around real clinical needs, not assumptions.” The resulting products are designed to be multi-functional and effective, combining the proprietary AVL SOM3® complex with well-established, clinical-grade actives to support skin barrier resilience, hydration, and radiance.

The scientific narrative is further bolstered by the inclusion of Dr. Dendy Engelman, a board-certified dermatologist, on the company's Scientific Advisory Board. Her dual perspective as both a physician and a mother who underwent IVF provides a powerful endorsement. "Patients are making deeply personal decisions about what they put in and on their bodies, and they deserve skincare that feels clear, considered, and grounded in real science," Dr. Engelman noted. "What excites me about AV Laboratories is that it brings together breakthrough science, elegant formulation, and a true understanding of women’s needs."

Redefining Holistic Patient Support

The launch of the Fertility Clinic Skincare Program taps into a significant, and growing, trend within medicine: the shift towards holistic, patient-centered care. Fertility clinics, in particular, are increasingly recognizing that patient success and satisfaction extend beyond clinical outcomes. The journey is often a marathon of stress, hormonal fluctuations, and intense self-scrutiny, creating a profound need for supportive care that addresses both mind and body.

During fertility treatments, pregnancy, and breastfeeding, many women become hyper-aware of product ingredients, seeking to avoid potentially harmful chemicals while still addressing skin concerns like hormonal acne, sensitivity, or melasma. This often leads to confusion and anxiety in the skincare aisle. AV Laboratories aims to solve this problem by providing a trusted, medically-aligned resource.

“We can’t keep separating these experiences into different categories anymore. Women’s health and skincare should be viewed as part of one connected journey,” said Jessica Martin, Director of Corporate Communication at AV Laboratories. “As a mom of two, I remember how important it was to feel confident in the products I used, especially while breastfeeding... We want to make at least one part of that journey feel simpler by creating skincare women can genuinely trust.”

The program is designed to be easily integrated into clinic workflows, offering educational materials, product recommendations, and wellness resources. According to Nathalie Boonen, an IVF and Medical Clinic Partnerships Expert cited by the company, this approach directly meets a patient need. “Women going through fertility treatment want guidance they can deeply rely on, in every aspect of their care, including what they can use on their skin,” she stated. “A thoughtful, science-backed skincare program gives clinics a simple way to meet that need and elevate the patients' experience.”

A New Business Model for Clinical Wellness

Beyond the patient benefits, AV Laboratories' strategy represents a savvy business model that targets a niche, high-value market. By embedding its program within the trusted ecosystem of a fertility clinic, the company bypasses the crowded consumer beauty market and establishes a powerful distribution channel built on medical authority.

For participating clinics, the program offers a way to enhance the patient experience, differentiate their practice in a competitive field, and potentially open up a new revenue stream through product sales or referral programs. However, the success of this model will depend on overcoming several hurdles. Clinics operate on tight schedules, and any new program must be simple to implement without disrupting the primary focus on medical care. Furthermore, physicians will need to be convinced of the program's scientific merit and safety.

AV Laboratories appears ready to address these challenges head-on at ESHRE 2026. The company’s plans for its booth include product sampling, in-depth education on its AVL SOM3® technology, and direct meetings with leadership to discuss partnership models. By engaging directly with clinicians, embryologists, and fertility specialists, the company is demonstrating its commitment to being a partner, not just a vendor.

This strategic launch positions AV Laboratories at the intersection of biotechnology, consumer wellness, and clinical medicine. By leveraging its unique scientific heritage, the company is making a compelling argument that supporting a patient's skin is an integral part of supporting their overall journey to parenthood.